Preventing Myeloma Progression with Diet - HealthTree for Multiple Myeloma
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Preventing Myeloma Progression with Diet: The Nutrivention-2 Study

Preventing Myeloma Progression with Diet: The Nutrivention-2 Study image

Preventing Myeloma Progression with Diet: The Nutrivention-2 Study

event Mar 04, 2025 / 11:00AM MST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Through her extensive (and continuing) research, Dr. Urvi Shah, a multiple myeloma specialist at Memorial Sloan Kettering Cancer Center, is determined to find answers to the often-asked question by patients with precursor myeloma conditions, “What diet is best for me?” l

Can a plant based diet affect your overall health? Can it affect your blood cancer progression or time to relapse? What does the science say about it, and what questions still need to be answered? Join us to discuss these topics and answer these questions and more. C

HealthTree is working with Dr. Urvi Shah's team at MSK in "Nutrivention-2", a national, multi-arm, randomized prospective telehealth study. This study will explore the microbial changes in response to a plant-based diet and supplements in smoldering myeloma patients. You can learn more about it HERE. If you're interested and want more information, please contact our support team - support@healthtree.org.

 

selected url

Schedule & Agenda

The panelist Jenny Ahlstrom
Welcome
11:00 AM
Jenny Ahlstrom

Welcome, Announcements & Introduction

The panelist Urvi Shah, MD
Discussion with Dr. Urvi Shah
11:05 AM
Urvi Shah, MD

Nutrivention-2 Study and how diet can prevent myeloma progression

Speakers & Moderators

The panelist Jenny Ahlstrom
Jenny Ahlstrom
Lehi, UT

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Urvi Shah, MD
Urvi Shah, MD

Dr. Urvi Shah is a faculty on the myeloma service, division of hematologic malignancies at Memorial Sloan Kettering Cancer Center. Her research focuses on studying the role of diet, microbiome, and other lifestyle-related risk factors in plasma cell disorders as well as identifying interventions to improve outcomes for these patients. She also studies immune therapies (including CAR T cell therapies) for myeloma. Being a lymphoma survivor herself she is passionate about helping patients make wise nutritional and lifestyle choices as they face a plasma cell disorder diagnosis as well as raising awareness about healthy choices to prevent cancer.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

All the HealthTree resources anywhere, anytime.
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Blood Cancer Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.